Article
Mismatch repair and treatment resistance in ovarian cancer
31 Jul 2006
Abstract excerpt
BACKGROUND: The treatment of ovarian cancer is hindered by intrinsic or acquired resistance to platinum-based chemotherapy. The aim of this study is to determine the frequency of mismatch repair (MMR) inactivation in ovarian cancer and its association with resistance to platinum-based chemotherapy. METHODS: We determined, microsatellite instability (MSI) as a marker for MMR inactivation (analysis of BAT25 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
